LDN stands for low dose naltrexone, a repurposed version of the drug naltrexone taken at a fraction of its standard dose. Naltrexone is FDA-approved for treating opioid and alcohol addiction at 50 to 100 mg per day. When the same drug is prescribed at just 0.5 to 6 mg, it appears to have an entirely different effect: reducing inflammation and modulating the immune system rather than blocking the effects of drugs or alcohol. LDN is not FDA-approved for these uses, but a growing number of physicians prescribe it off-label for chronic pain, autoimmune conditions, and neurological diseases.
How LDN Works in the Body
Naltrexone blocks opioid receptors in the brain. At full doses, this blockade lasts all day, which is why it helps people in addiction recovery by preventing a high from opioids or alcohol. At very low doses, the blockade is brief, lasting only a few hours. What happens after that brief blockade is where things get interesting, and also where the science gets complicated.
For years, the leading theory was that LDN’s short-lived receptor blockade triggered the body to produce more endorphins, its natural painkillers, as a rebound effect. This idea made intuitive sense and became widely repeated. However, a study published in eNeuro found no evidence to support it. Researchers measured endorphin levels, the activity of the cells that produce them, and the sensitivity of opioid receptors in animals treated with LDN. None of these changed compared to a placebo group.
The mechanism that has gained more traction involves the immune system. Naltrexone, even at low doses, appears to block a specific receptor on immune cells in the brain and spinal cord called Toll-like receptor 4 (TLR4). These immune cells, called microglia, are the brain’s first responders to injury and infection. When they become chronically activated, they drive neuroinflammation, a process linked to chronic pain, fatigue, and autoimmune flare-ups. By dialing down this overactivation, LDN acts as what researchers call a “glial attenuator,” calming the inflammatory response rather than simply blocking pain signals.
Conditions LDN Is Used For
LDN is prescribed most often for conditions involving chronic pain or immune dysfunction. The strongest clinical evidence so far exists for fibromyalgia. A systematic review and meta-analysis found that LDN significantly reduced pain severity compared to placebo, with a moderate-to-large effect size. When researchers excluded one outlier study, the effect became even stronger and the results were highly consistent across trials. That said, LDN did not raise mechanical pain thresholds, meaning it may change how the brain processes pain rather than making tissues less sensitive to pressure.
Multiple sclerosis is another condition where LDN has drawn attention. At least three clinical trials have reported that LDN improved quality of life and mental health in patients with relapsing-remitting or secondary progressive MS. Long-term follow-up data showed that patients tolerated LDN well, with fatigue levels remaining stable or decreasing and no serious adverse effects recorded.
In Crohn’s disease, the evidence is earlier-stage. One trial in adults found that 30% of patients on LDN achieved clinical remission at 12 weeks, compared to 18% on placebo. That difference was not statistically significant given the small sample size. A pediatric study showed more promising numbers, with 25% of LDN-treated children reaching remission compared to none on placebo, but the data was difficult to separate from an open-label extension phase. Physicians also prescribe LDN for other autoimmune and pain conditions including complex regional pain syndrome, chronic fatigue syndrome, and certain dermatological conditions, though large controlled trials for most of these are still lacking.
What to Expect When Starting LDN
LDN is not a fast-acting treatment. Most patients need at least one to three months before noticing meaningful pain relief. In one case series, 72% of patients who responded saw initial improvement somewhere in that one-to-three-month window, while 12% didn’t experience benefits until after three months. This slow onset is one reason some people abandon the treatment too early. Physicians who prescribe LDN typically advise completing a full course before judging whether it works.
Doctors usually start with a very low dose, often around 0.5 to 1.5 mg, and gradually increase over several weeks to the target range of 3 to 4.5 mg. This gradual approach helps minimize side effects during the adjustment period. Most people take LDN once daily, typically at bedtime, though some prescribers recommend morning dosing if sleep disturbances occur.
Side Effects
LDN is generally well tolerated, and most studies describe side effects as mild and often temporary. The most commonly reported issue is nausea. Fatigue, vivid dreams, insomnia, headaches, and anxiety also show up in patient reports, though at lower rates. In one retrospective analysis of a pain clinic’s patients, nausea was the most frequent complaint, followed by fatigue, then vivid dreams and insomnia at roughly equal rates. For many patients, these effects diminish within the first few weeks as the body adjusts.
A Critical Interaction With Opioid Painkillers
Because LDN affects opioid receptors, it cannot be taken alongside opioid medications. This includes prescription painkillers like oxycodone, hydrocodone, morphine, and fentanyl, as well as some cough medications. The interaction works in two directions, and both are dangerous.
First, taking LDN while opioids are still in your system can trigger sudden withdrawal. Second, and less obvious, chronic LDN use may make your body hypersensitive to opioids if you later take them. In one documented case, a patient with MS who had been on LDN received a single 5 mg dose of oxycodone. The result was severe unresponsiveness requiring emergency naloxone treatment and an overnight stay in intensive care. The likely explanation is that LDN had upregulated the patient’s opioid receptors, making a normal dose dangerously potent. Anyone on LDN should make sure their doctors, including emergency physicians and anesthesiologists, know about it.
Why You Need a Compounding Pharmacy
Naltrexone is commercially manufactured only in 50 mg tablets (and as a monthly injection for addiction treatment). Since LDN requires doses between 0.5 and 6 mg, standard tablets can’t simply be cut into the right amount. Instead, LDN prescriptions must be filled by a compounding pharmacy, which custom-prepares medications in non-standard doses. The pharmacist takes naltrexone and formulates it into the precise milligram amount your doctor prescribes, usually as a capsule or liquid.
This adds a step to the process that can feel unfamiliar. You need a prescriber willing to write an off-label prescription and a compounding pharmacy to fill it. Not every doctor is comfortable prescribing LDN, and not every pharmacy compounds it, so finding both can take some effort depending on where you live. Some patients use telehealth consultations with physicians experienced in LDN prescribing, paired with mail-order compounding pharmacies that ship nationwide. Because LDN is compounded rather than mass-produced, it is typically not covered by insurance, though the out-of-pocket cost is often modest, generally in the range of $30 to $50 per month.